Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase InhibitorsUltan McDermott, Jeffrey Settleman, Hannah Stubbs et al.|Cancer Research|2009Cited by 98
Supplementary Figure 6 from Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase InhibitorsUltan McDermott, Jeffrey Settleman, Mark G. Erlander et al.|Unknown|2023Cited by 0
Supplementary Figure 4 from Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase InhibitorsUltan McDermott, Jeffrey Settleman, Daniel A. Haber et al.|Unknown|2023Cited by 0
Supplementary Figure 3 from Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase InhibitorsUltan McDermott, Jeffrey Settleman, Daniel A. Haber et al.|Unknown|2023Cited by 0